Purple Biotech (PPBT) Non-Current Assets (2017 - 2021)

Purple Biotech (PPBT) has disclosed Non-Current Assets for 4 consecutive years, with $21.7 million as the latest value for Q4 2021.

  • On a quarterly basis, Non-Current Assets rose 135681.25% to $21.7 million in Q4 2021 year-over-year; TTM through Dec 2021 was $21.7 million, a 135681.25% increase, with the full-year FY2021 number at $21.7 million, up 135681.25% from a year prior.
  • Non-Current Assets was $21.7 million for Q4 2021 at Purple Biotech, up from $16000.0 in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $21.7 million in Q4 2021 to a low of $9000.0 in Q4 2018.
  • A 4-year average of $5.4 million and a median of $20000.0 in 2019 define the central range for Non-Current Assets.
  • Peak YoY movement for Non-Current Assets: crashed 33.33% in 2020, then skyrocketed 135681.25% in 2021.
  • Purple Biotech's Non-Current Assets stood at $9000.0 in 2018, then surged by 166.67% to $24000.0 in 2019, then crashed by 33.33% to $16000.0 in 2020, then surged by 135681.25% to $21.7 million in 2021.
  • Per Business Quant, the three most recent readings for PPBT's Non-Current Assets are $21.7 million (Q4 2021), $16000.0 (Q4 2020), and $24000.0 (Q4 2019).